tirzepatide weight loss clinical trials New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss LiveGood Clinic

NO CONTM GLTEN

Red Mountain Weight Loss products, as a branded range from a US clinic, do not hold MHRA marketing authorisation and are therefore not licensed for sale in the UK

Synergistic Regulation of Gastrointestinal Function Influencing Gastrointestinal Hormone Secretion: GLP-1R agonists stimulate GLP-1 secretion, while GIPR agonists regulate GIP release

Tirzepatide is FDA-approved and available now as Mounjaro/Zepbound

Contact Keystone Pharmacy today to learn more about how we can help you manage your condition more effectively.

California Proposition 65 WARNING: Consuming this product can expose you to chemicals including lead and cadmium which are known to the State of California to cause cancer and birth defects or other reproductive harm